Journal of Hepatology
Volume 50, Issue 3 , Pages 584-591, March 2009

Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: An open label trial☆

  • Praveen Sharma

      Affiliations

    • Department of Gastroenterology, G B Pant Hospital, Affiliated to University of Delhi, 201, Academic Block, Jawahar Lal Nehru Road, New Delhi 110 002, India
    • Department of Hepatology, Institute of Liver & Biliary Sciences (ILBS), New Delhi, India
    • ,
  • Ashish Kumar

      Affiliations

    • Department of Gastroenterology, G B Pant Hospital, Affiliated to University of Delhi, 201, Academic Block, Jawahar Lal Nehru Road, New Delhi 110 002, India
    • Department of Hepatology, Institute of Liver & Biliary Sciences (ILBS), New Delhi, India
    • ,
  • Barjesh Chander Sharma

      Affiliations

    • Department of Gastroenterology, G B Pant Hospital, Affiliated to University of Delhi, 201, Academic Block, Jawahar Lal Nehru Road, New Delhi 110 002, India
    • ,
  • Shiv Kumar Sarin

      Affiliations

    • Department of Gastroenterology, G B Pant Hospital, Affiliated to University of Delhi, 201, Academic Block, Jawahar Lal Nehru Road, New Delhi 110 002, India
    • Department of Hepatology, Institute of Liver & Biliary Sciences (ILBS), New Delhi, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 23232013; fax: +91 11 23219710.

Received 7 February 2008; received in revised form 14 October 2008; accepted 23 October 2008. published online 22 December 2008.

Associate Editor: C.P. Day

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The abstract of this work was presented at the Annual Conference of the American College of Gastroenterology (ACG), November, 2007. The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drug involved either in the past or present and they did not receive funding from the manufacturers to carry out their research.

PII: S0168-8278(08)00792-7

doi:10.1016/j.jhep.2008.10.024

Journal of Hepatology
Volume 50, Issue 3 , Pages 584-591, March 2009

Article Tools

* Image Usage & Resolution